This message was sent to ##Email##
|
|
|
|
|
National Cancer Institute
The aging of the U.S. population will result in a substantial increase in the number of older cancer survivors over the next quarter century, particularly those 85 and older, according to a new study by NCI researchers.
Using statistical models to analyze population data, the researchers estimated that the overall number of cancer survivors in the United States will continue to grow substantially.
READ MORE
NPCRC
The Commission on Cancer is dedicated to supporting cancer program efforts that reduce the burden of cancer while improving the cancer experience through palliative care. For cancer programs with onsite palliative care services, the National Palliative Care Registry™ is accepting palliative care program data for 2015. Participation in this registry is not a requirement of the CoC.
The Registry is a joint project of the Center to Advance Palliative Care (CAPC) and the National Palliative Care Research Center (NPCRC). It provides actionable data that programs can use to secure, expand and retain resources for delivery of high-quality palliative care, and to support the establishment of new palliative care programs where none exist. The Registry has recently expanded to include community-based settings, including palliative care services embedded in cancer programs.
The Registry is free and open to all. Please share this information with your palliative care program partner as a reminder to submit their 2015 data. Programs can learn more and enter data here.
READ MORE
|
Promoted by
|
|
|
|
 |
JAMA Internal Medicine
Cancer centers advertise to reach patients and their families in a very competitive market. Patients often have dangerous cancers and face toxic treatments, and the advertisements offer hope. But the hope can — and often does — morph into hype. After all, this is advertising. Medicine has long been ambivalent about advertising services. The AMA's original code of ethics banned advertising as "derogatory to the profession" and "reprehensible" until forced to relent by federal courts in 1980. However, as Vater et al show in this issue of JAMA Internal Medicine, the marketing of cancer services is growing. An essential question is how to ensure that advertisers do not take advantage of vulnerable patients.
READ MORE
MedPage Today
Almost 12 percent of men with metastatic prostate cancer had germline DNA-repair mutations, a finding that could help guide therapy selection toward nonstandard agents for selected patients, genetic sequencing data for 700 patients suggested. The frequency of inherited DNA-repair mutations was almost three times higher than rates observed in men with localized prostate cancer.
READ MORE
| |
PRODUCT SHOWCASE | Advertisement
|
 |
|
Enjoy our journals? There’s an app for those! Journals such as those from the American Cancer Society ™, Journal of Surgical Oncology, Cancer Science and more are now available for your iPad and iPhone. Sample issues and abstracts, as well as open articles, can be accessed for free. A subscription to the journal is required to read the full text.
|
|
ACS
Accreditation 101: Learning the Basics of CoC Accreditation and Standards will be held Sept. 9 in Chicago. This one-day program, taught by CoC surveyors and staff, provides an overview of the CoC accreditation standards and answers your questions about the standards and the survey process. This is the last time this program will be held in 2016.
Renal & Urology News
Men with low-risk prostate cancer (PCa) are more likely to receive expectant management for their disease if they are evaluated at academic rather than community centers, new findings suggest. Using the National Cancer Database, Nathaniel H. Lester-Coll, MD, of Yale University School of Medicine in New Haven, Connecticut, and colleagues performed a retrospective analysis of 2010-2013 data on 91,556 men with low-risk PCa.
READ MORE
| |
SPONSORED CONTENT | Advertisement
|
|
Promoted by
|
|
|
|
 |
Medical News Today
People who have diabetes may have a higher chance of developing cancer either before or immediately after receiving a diagnosis of diabetes, according to a study published online in the American Cancer Society's journal, Cancer. The results indicate that there is a need for better understanding of the association between cancer and diabetes.
READ MORE
The Cancer Support Community is interested in understanding the experiences of people accessing
cancer care in the new and evolving healthcare system. Your input will help us understand the
issues and experiences that patients have accessing cancer care, and allow us to identify the
necessary steps to ensure that the healthcare system is adequately serving people affected by
cancer.Take the survey.
|
|
Advertisement
 |
|
For the past 22 years, EduCare's mission has been to support Healthcare Professionals in educating breast cancer patients. We strive to offer products that are patient-friendly and up-to-date. Patient education increases compliance, reduces time constraints and promotes a partnership between patient and healthcare providers.
|
|
|
|
|
Advertisement
 |
|
Specialty Practice Management is a complete front- and back-office solution that offers a rapid return on your investment and improved satisfaction among your staff. Practices with 10 or fewer providers turn to this comprehensive solution to manage self-pay accounts and eliminate common mistakes.
|
|
|
|
Life Science Daily
The Centers for Disease Control and Prevention (CDC) recently found that U.S. healthcare facilities can support the new national colorectal screening goal of ensuring that at least 80 percent of adults ages 50-75 get screened for the cancer.
Colorectal cancer is the second-leading cause of cancer-related deaths for both men and women, but early screening can save lives. In an effort to decrease the disease's prevalence, the U.S. government set a goal of screening 80 percent of older adults for the cancer regularly. The CDC was tasked with determining if the capacity of U.S. healthcare could support that goal, when only half of older adults currently get screened for colorectal cancer.
READ MORE
AJCC
The AJCC announces five disease site webinars that are scheduled for summer and early fall this year. The webinars, offered at no cost, will provide highlights of the five most common site chapters for AJCC 7th edition staging and include: Melanoma, Lung, Breast, Colorectum and Prostate. There will be pre- and post-education quizzes to serve as a self-assessment for the information learned. The webinars will provide information on the uniqueness, differences, exceptions or special concerns for the disease sites.
Each lecture will contain the following topics:
Overview and Learning Objectives
Anatomy Affecting Stage
Classification Issues
Assigning T, N, M, Stage Group
Information and Questions on AJCC Staging and Summary
The first live webinar (Melanoma) will occur on July 27. The second webinar (Lung) will be
held Aug. 16. The webinars will be recorded for anyone who is not able to attend the live session. Register now.
You can visit the AJCC website to learn more about the Disease Site webinars and stay informed.
Renal & Urology News
For men with metastatic prostate cancer (mPCa), overall survival is improved for those treated with androgen deprivation therapy and prostate radiotherapy, compared with ADT alone, according to a study published online in the Journal of Clinical Oncology.
Chad G. Rusthoven, MD, from the University of Colorado School of Medicine in Aurora, and colleagues examined the OS of men with mPCa treated with ADT, with and without prostate RT, using data from the National Cancer Database. A total of 6,382 men with mPCa were identified, of whom 8.4 percent received prostate RT.
READ MORE
For additional information, please complete the mailing list request form.
|
|
|
Advertisement
Advertisement
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
